Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)

NCT06195267 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Aortic Dissection
Systemic Inflammatory Response Syndrome
Cardiovascular Diseases (CVD)

Interventions

DRUG: Sivelestat
DRUG: Blank control

Sponsor

Nanjing Medical University

Collaborators

[object Object]
[object Object]